Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Drug Overdose

imatinib mesylate has been researched along with Drug Overdose in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatelut, E; Dehours, E; Fourcade, O; Huguet, F; Recher, C; Riu, B; Valle, B1
Iketani, O; Kawamura, S; Okamoto, S; Ueda, T; Yamaguchi, M; Yamayoshi, Y1
Bhargav, R; Kumar, R; Mahapatra, M; Mishra, P1

Other Studies

3 other study(ies) available for imatinib mesylate and Drug Overdose

ArticleYear
Overdose with 16,000 mg of imatinib mesylate.
    Leukemia research, 2010, Volume: 34, Issue:10

    Topics: Antineoplastic Agents; Benzamides; Drug Overdose; Electrocardiography; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Pyrimidines

2010
Suicide attempt with an overdose of imatinib.
    British journal of clinical pharmacology, 2012, Volume: 74, Issue:5

    Topics: Antineoplastic Agents; Azepines; Benzamides; Drug Overdose; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Middle Aged; Piperazines; Pyrimidines; Suicide, Attempted; Triazolam

2012
Overdose with 6400 mg of imatinib: is it safe?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:10

    Topics: Adult; Antineoplastic Agents; Benzamides; Drug Overdose; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines

2007